Affymetrix

Oberweis: Small Cap Favorites

"Despite a very tough environment, buying shares in good companies which are performing well should bear fruit over time," says Jim Oberweis, Jr. In The Oberweis Report, he adds, "We’ve put together a list of our top ideas that...

Affymetrix To Acquire Panomics

Affymetrix (Booth 631) has entered into a definitive agreement to acquire Panomics Inc., a privately held Fremont, CA-based company that offers a suite of assay products for a wide variety of low to mid-plex genetic, protein...

NuGEN Expands Executive Team With Finance and Marketing Pros

News source: Business Wire NuGEN Technologies, Inc., a privately held company that develops and commercializes nucleic acid amplification and sample preparation systems, announced today that it has hired Daniel Benetz to serve...

Genetic Switch Found For Common Childhood Tumor

Endothelial cells that line affected blood vessels in infantile hemangioma, the most common childhood tumor, appear to be derived from the same abnormal cell. Additional topics at Children's health More disease-related research...

Ten Under The Radar Small And Micro-Cap Value Stocks (Healthcare)

The accompanying table presents 10 small and micro-cap companies from a variety of industries which are trading at value parameters, with average valuations for the group of 0.54X trailing 12-month sales, 0.44X enterprise value...

Examine the DNA Diagnostics: Technologies and Global Markets

Examine the DNA Diagnostics: Technologies and Global MarketsNEW YORKNY-REPORTLINKER NEW YORK--(BUSINESS WIRE)-- INTRODUCTION STUDY GOALS AND OBJECTIVES REASONS FOR DOING THE STUDY SCOPE OF REPORT INTENDED AUDIENCE METHODOLOGY...

Affymetrix Gets Specific (at Motley Fool)

Affymetrix (Nasdaq: AFFX), a company that I figured Invitrogen (Nasdaq: IVGN) or Thermo Fisher (NYSE: TMO) would snatch up after its free fall, has decided to do some acquiring of its own. Yesterday, the company announced that...

Affymetrix Announces New Cost-effective Product for Standardizing Drug Metabolism Studies

SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov 11, 2008 - Affymetrix, Inc. (Nasdaq:AFFX) today announced the DMET(TM) Plus Premier Pack, the most comprehensive method for standardizing drug metabolism studies. The DMET (Drug...

Affymetrix to pay $73M for privately held Panomics

Affymetrix Inc., which makes equipment for genetic data analysis, said Tuesday it will pay $73 million to acquire privately held Panomics. Affymetrix said the purchase would broaden its genetic and cellular analysis offerings.

InPlay: Sanofi-Aventis announces data from ATHENA trial showed dronedarone significantly reduced...

11:49AM European Markets Closing Prices: FTSE: 4255.8 -148.1 -3.4%, DAX: 4762.4 -263.1 -5.2%, CAC: 3336.4 -169.3 -4.8% : 11:25AM Cousins Prop announces $20 mln Series A and Series B Preferred Stock repurchase plan 11.71 -0.63 :...

1 2 3 4 next »